ABHD17AP9

Across TCGA pan-cancer cohorts, ABHD17AP9 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated ABHD17AP9 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ABHD17AP9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ABHD17AP9 expression acts as an unfavorable survival marker.

UCEC, BLCA, and LAML are the cancer types where ABHD17AP9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	III,IV	0.066	0.830	<.001	72	view →
BLCA	DFS	Tertile	All	0.132	0.626	.006	27	view →
LAML	DFS	Tertile	All	0.147	0.401	.028	18	view →
HNSC	OS	Tertile	All	0.187	0.685	.042	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

ABHD17AP9–UCEC (OS)

Open the UCEC breakdown →